PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Update

Go back to PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Update

PDS Biotechnology (PDSB) Tops Q3 EPS by 10c

November 14, 2023 7:33 AM EST

PDS Biotechnology (NASDAQ: PDSB) reported Q3 EPS of ($0.35), $0.10 better than the analyst estimate of ($0.45).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

... More